Control of Focal Adhesion Kinase Activation by RUNX1-Regulated miRNAs in High-Risk AML

Scientists integrated existing molecular subtyping approach for myeloid malignancies based on RNA-Seq with analysis of miRNA expression in high- and low-AML prognostic score AML cases, to better understand how dysregulation of the non-coding transcriptome contributes to disease pathogenesis.